COVID-19

COVID-19 vaccines for children: An expert explains

The Pfizer/BioNTech vaccine is set to be approved for children aged 5-11 in the United States. Image: REUTERS/Dado Ruvic/File Photo/File Photo

Kate McAlpine

Senior news and feature writer, Michigan College of Health

Share:

Our Impact
The Big Picture
Explore and monitor how COVID-19 is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

COVID-19

Cumulative confirmed COVID-19 cases in the United States. Image: Our World in Data

Have you read?

Discover

India’s leading COVID-19 last-mile responders

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

COVID-19Pandemic Preparedness and ResponseGlobal Health

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

COVID-19 variants: Will existing rapid antigen tests be able to detect new strains?
About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum